Cargando…

Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer

SIMPLE SUMMARY: Ligand-independent androgen receptor splice variants emerge during androgen deprivation therapy and are suspected to render prostate carcinomas castration-resistant. In a retrospective analysis of a large cohort of primary and advanced prostate tumors, we observed increased expressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tolkach, Yuri, Kremer, Anika, Lotz, Gábor, Schmid, Matthias, Mayr, Thomas, Förster, Sarah, Garbe, Stephan, Hosni, Sana, Cronauer, Marcus V., Kocsmár, Ildikó, Kocsmár, Éva, Riesz, Péter, Alajati, Abdullah, Ritter, Manuel, Ellinger, Jörg, Ohlmann, Carsten-Henning, Kristiansen, Glen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496991/ https://www.ncbi.nlm.nih.gov/pubmed/36139600 http://dx.doi.org/10.3390/cancers14184441

Ejemplares similares

Addition of Chromosome 17 Polysomy and HER2 Amplification Status Improves the Accuracy of Clinicopathological Factor-Based Progression Risk Stratification and Tumor Grading of Non-Muscle-Invasive Bladder Cancer
por: Kocsmár, Ildikó, et al.
Publicado: (2022)

Comment on Skrebinska et al. Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection? Diagnostics 2022, 12, 133
por: Kocsmár, Éva, et al.
Publicado: (2022)

Prognostic Ability of Tumor Budding Outperforms Poorly Differentiated Clusters in Gastric Cancer
por: Szalai, Luca, et al.
Publicado: (2022)

Cross-testing of major molecular markers indicates distinct pathways of tumorigenesis in gastric adenocarcinomas and synchronous gastrointestinal stromal tumors
por: Kocsmár, Éva, et al.
Publicado: (2020)

Proteome alterations in human autopsy tissues in relation to time after death
por: Kocsmár, Éva, et al.
Publicado: (2023)

Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study
por: Kim, Jewel Ju Ea, et al.
Publicado: (2021)

Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides
por: Kocsmár, Éva, et al.
Publicado: (2021)

Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers
por: Kremer, Anika, et al.
Publicado: (2019)

CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma
por: Frey, Lisa, et al.
Publicado: (2021)

The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma
por: Cox, A., et al.
Publicado: (2020)

Apelin and apelin receptor expression in renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2019)

Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer
por: Stinnesbeck, Melissa, et al.
Publicado: (2021)

CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2–ERG-Positive Primary Prostate Cancers
por: von Danwitz, Marthe, et al.
Publicado: (2023)

Prognostic impact of tumor budding and EMT in periampullary adenocarcinoma: a quantitative approach
por: Kocsmár, Éva, et al.
Publicado: (2020)

Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA
por: Kristiansen, Ilka, et al.
Publicado: (2017)

Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers
por: Klümper, Niklas, et al.
Publicado: (2020)

Systematic expression analysis of m(6)A RNA methyltransferases in clear cell renal cell carcinoma
por: Gundert, Larissa, et al.
Publicado: (2021)

Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma
por: Ellinger, Jörg, et al.
Publicado: (2016)

YRNA expression predicts survival in bladder cancer patients
por: Tolkach, Yuri, et al.
Publicado: (2017)

Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma
por: Heinemann, Frauke G., et al.
Publicado: (2018)

Prostate-specific membrane antigen expression in hepatocellular carcinoma: potential use for prognosis and diagnostic imaging
por: Tolkach, Yuri, et al.
Publicado: (2019)

Inflammatory fibroid polyp of the renal pelvis: first report at an extra-gastrointestinal site with molecular confirmation
por: Nagy, Dora, et al.
Publicado: (2023)

Prostate cancer treatment costs increase more rapidly than for any other cancer—how to reverse the trend?
por: Ellinger, J., et al.
Publicado: (2022)

RNA Sequencing Reveals Alterations and Similarities in Cell Metabolism, Hypoxia and Immune Evasion in Primary Cell Cultures of Clear Cell Renal Cell Carcinoma
por: Simon, Adrian Georg, et al.
Publicado: (2022)

Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behavior
por: Simon, Adrian Georg, et al.
Publicado: (2020)

Loss of cadherin related family member 5 (CDHR5) expression in clear cell renal cell carcinoma is a prognostic marker of disease progression
por: Bläsius, Felix Marius, et al.
Publicado: (2017)

Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell Carcinoma
por: Brüggemann, Maria, et al.
Publicado: (2017)

Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper
por: Golubnitschaja, Olga, et al.
Publicado: (2022)

Early Dynamics of Quantitative SEPT9 and SHOX2 Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis
por: Krausewitz, Philipp, et al.
Publicado: (2022)

CD103+ Tissue Resident T-Lymphocytes Accumulate in Lung Metastases and Are Correlated with Poor Prognosis in ccRCC
por: Sanders, Christine, et al.
Publicado: (2022)

Adipophilin as prognostic biomarker in clear cell renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2017)

Downstream neighbor of SON (DONSON) is associated with unfavorable survival across diverse cancers with oncogenic properties in clear cell renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2020)

Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer
por: Perner, Sven, et al.
Publicado: (2015)

DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men—study protocol for a randomized trial
por: Krausewitz, P., et al.
Publicado: (2023)

Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study
por: Krausewitz, Philipp, et al.
Publicado: (2022)

Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells
por: Cronauer, M V, et al.
Publicado: (2000)

Effects of Sorafenib on C-Terminally Truncated Androgen Receptor Variants in Human Prostate Cancer Cells
por: Zengerling, Friedemann, et al.
Publicado: (2012)

Inhibition of Glycogen Synthase Kinase-3β Counteracts Ligand-Independent Activity of the Androgen Receptor in Castration Resistant Prostate Cancer
por: Schütz, Stefanie V., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0edmiqcjhs8dvv7ot15di6m0d5